Publikationen in Zusammenarbeit mit Forschern von Instituto de Parasitología y Biomedicina López Neyra (20)

2024

  1. The expression of immune response genes in patients with chronic Chagas disease is shifted toward the levels observed in healthy subjects as a result of treatment with Benznidazole

    Frontiers in Cellular and Infection Microbiology, Vol. 14

2023

  1. Differential expression profile of genes involved in the immune response associated to progression of chronic Chagas disease

    PLoS Neglected Tropical Diseases, Vol. 17, Núm. 7

2021

  1. A proportion of cd4+ t cells from patients with chronic chagas disease undergo a dysfunctional process, which is partially reversed by benznidazole treatment

    PLoS Neglected Tropical Diseases, Vol. 15, Núm. 2, pp. 1-25

  2. Differential Expression of Immune Response Genes in Asymptomatic Chronic Chagas Disease Patients Versus Healthy Subjects

    Frontiers in Cellular and Infection Microbiology, Vol. 11

2020

  1. Differential phenotypic and functional profile of epitope-specific cytotoxic CD8+ T cells in benznidazole-treated chronic asymptomatic Chagas disease patients

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 3

  2. Immunological exhaustion and functional profile of CD8+ T lymphocytes as cellular biomarkers of therapeutic efficacy in chronic Chagas disease patients

    Acta Tropica, Vol. 202

2019

  1. A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 10

  2. An observational longitudinal study to evaluate tools and strategies available for the diagnosis of Congenital Chagas Disease in a non-endemic country

    Acta Tropica, Vol. 199

2018

  1. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+T cells in chronic Chagas disease patients

    PLoS Neglected Tropical Diseases, Vol. 12, Núm. 5

2017

  1. Expression of inhibitory receptors and polyfunctional responses of T cells are linked to the risk of congenital transmission of T. cruzi

    PLoS Neglected Tropical Diseases, Vol. 11, Núm. 6

2016

  1. A 12-mer repetitive antigenic epitope from Trypanosoma cruzi is a potential marker of therapeutic efficacy in chronic Chagas' disease

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 7, pp. 2005-2009

2015

  1. Differential phenotypic and functional profiles of TcCA-2-specific cytotoxic CD8+ T cells in the asymptomatic versus cardiac phase in chagasic patients

    PLoS ONE, Vol. 10, Núm. 3

2014

  1. The innate immune response status correlates with a divergent clinical course in congenital Chagas disease of twins born in a non-endemic country

    Acta Tropica, Vol. 140, pp. 84-90

2013

  1. Benznidazole treatment reduces the induction of indoleamine 2,3-dioxygenase (IDO) enzymatic activity in Chagas disease symptomatic patients

    Parasite Immunology, Vol. 35, Núm. 5-6, pp. 180-187

  2. Risk factors and primary prevention of congenital chagas disease in a nonendemic country

    Clinical Infectious Diseases, Vol. 56, Núm. 4, pp. 496-502

2012

  1. Characterization of an immunodominant antigenic epitope from Trypanosoma cruzi as a biomarker of chronic Chagas' disease pathology

    Clinical and Vaccine Immunology, Vol. 19, Núm. 2, pp. 167-173

  2. Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8+ T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients

    Molecular Immunology, Vol. 52, Núm. 3-4, pp. 289-298

2011

  1. Identification of HLA-A*02:01-restricted CTL epitopes in Trypanosoma cruzi heat shock protein-70 recognized by Chagas disease patients

    Microbes and Infection, Vol. 13, Núm. 12-13, pp. 1025-1032

  2. Short-term follow-up of chagasic patients after benznidazole treatment using multiple serological markers

    BMC Infectious Diseases, Vol. 11

2008

  1. Mesa redonda 10: Arrays en el diagnóstico de enfermedades infecciosas: Fundamentos y perspectivas

    Enfermedades Emergentes